These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3123611)

  • 21. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethinyl oestradiol plus dl-norgestrel or levonorgestrel in the Yuzpe method for post-coital contraception: results of an observational study.
    Sánchez-Borrego R; Balasch J
    Hum Reprod; 1996 Nov; 11(11):2449-53. PubMed ID: 8981131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical experience with a triphasic oral contraceptive.
    Ulstein M; Svendsen E; Steier A; Bratt H; Fylling P; Lie S; Schiefloe A; Aaserud J
    Acta Obstet Gynecol Scand; 1984; 63(3):233-6. PubMed ID: 6428157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
    Carlborg L
    Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated prolactin levels in oral contraceptive pill-related hypertension.
    Lehtovirta P; Ranta T; Seppälä M
    Fertil Steril; 1981 Apr; 35(4):403-5. PubMed ID: 6783445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case of ectopic pregnancy after postcoital contraception with ethinyloestradiol-levonorgestrel.
    Kubba AA; Guillebaud J
    Br Med J (Clin Res Ed); 1983 Nov; 287(6402):1343-4. PubMed ID: 6416402
    [No Abstract]   [Full Text] [Related]  

  • 28. [Massive, painful hepatomegaly, sinusoidal dilatation and prolonged use of estroprogestational agents].
    Fischer D; Kémény F; Rauturseau J; Marty M; Karsenti P
    Gastroenterol Clin Biol; 1982 Mar; 6(3):302-4. PubMed ID: 7095347
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatocarcinoma and oral contraceptives.
    Trias R; Rius X; Autonell J; Algaba F
    Lancet; 1978 Apr; 1(8068):821. PubMed ID: 85833
    [No Abstract]   [Full Text] [Related]  

  • 30. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception.
    Russowsky M; Sartoretto JN
    Contraception; 1982 Jul; 26(1):41-9. PubMed ID: 7128133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Carpal tunnel syndrome caused by oral contraceptives].
    Tordesillas Lia C; Rodríguez de la Serna A; Pradas Orozco J; Illa Sendra I
    Rev Clin Esp; 1985 Jun; 177(1):46. PubMed ID: 4035041
    [No Abstract]   [Full Text] [Related]  

  • 33. Tracheo-oesophageal fistula associated with hormonal contraception during pregnancy.
    Frost O
    Br Med J; 1976 Oct; 2(6042):978. PubMed ID: 974713
    [No Abstract]   [Full Text] [Related]  

  • 34. Chorea associated with the use of oral contraceptives: report of a case and review of the literature.
    Wadlington WB; Erlendson IW; Burr IM
    Clin Pediatr (Phila); 1981 Dec; 20(12):804-6. PubMed ID: 7307418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe and prolonged oral contraceptive jaundice.
    Lieberman DA; Keeffe EB; Stenzel P
    J Clin Gastroenterol; 1984 Apr; 6(2):145-8. PubMed ID: 6715853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Acne stimulation by Ovral.
    Woodward RK
    Arch Dermatol; 1974 Nov; 110(5):812. PubMed ID: 4278638
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemichorea and oral contraceptives].
    Buge A; Vincent D; Rancurel G; Chéron F
    Rev Neurol (Paris); 1985; 141(10):663-5. PubMed ID: 4089398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Romus MA; Gillain D; Duvivier J; Demey-Ponsart E; Franchimont P
    Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
    Landgren BM; Diczfalusy E
    Contraception; 1984 May; 29(5):437-46. PubMed ID: 6430642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical data on the use of current oral contraceptives].
    Krymskaia ML; Khomasuridze AG
    Akush Ginekol (Mosk); 1983 Nov; (11):19-22. PubMed ID: 6666790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.